台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    90.3
  • 漲跌
    ▲0.4
  • 漲幅
    +0.44%
  • 成交量
    308
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智擎 (4162)籌碼相關-元大-鳳山 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0805/1805/2803/2004/0104/1404/2405/0605/30708090100110Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

元大-鳳山 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/19292.70292.9091.4001,1890.00%
2025/05/16191.2000.0090.9011,2090.08%
2025/05/1400.00290.5091.60-21,258-0.16%
2025/05/1200.004090.9090.60-401,298-3.08%
2025/05/081089.2500.0089.60101,4150.71%
2025/05/071087.5000.0087.70101,4730.68%
2025/05/06186.7000.0087.7011,6570.06%
2025/05/051986.9800.0087.70191,7641.08%
2025/04/2500.00488.7587.90-41,779-0.22%
2025/04/2400.00488.0087.70-41,774-0.23%
2025/04/2200.00185.4085.50-11,777-0.06%
2025/04/0900.00177.0076.50-11,844-0.05%
2025/04/08181.00281.5084.60-11,801-0.06%
2025/04/01297.8000.0097.3021,7730.11%
2025/03/2100.000106.00106.5001,7140.00%
2025/03/180107.0000.00106.5001,7130.00%
2025/03/170107.0000.00105.0001,7140.00%
2025/03/121108.0000.00107.0011,6950.06%
2025/03/113105.173106.67107.0001,6970.00%
2025/03/1000.000.1107.00107.00-0.11,6860.00%
2025/03/0711107.9511107.68107.5001,6650.00%
2025/03/0610112.0010111.00111.0001,6470.00%
2025/03/032.1113.9800.00112.502.11,6200.13%
2025/02/261117.5000.00115.5011,5530.06%
2025/02/250114.5000.00113.0001,4430.00%
2025/02/2400.000.1114.00115.00-0.11,4310.00%
2025/02/210113.0000.00113.0001,4120.00%
2025/02/203111.0000.00110.0031,3890.22%
2025/02/185.1109.015111.00110.000.11,4010.00%
2025/02/1700.001112.00112.50-11,397-0.07%
2025/02/142111.001110.50111.5011,4080.07%
2025/02/112112.254111.75109.00-21,392-0.14%
2025/02/073119.000118.00120.5031,3510.22%
2025/02/067119.867119.71119.0001,3290.00%
2025/01/090.197.2000.0094.600.11,3410.00%
2024/12/23087.2000.0087.0001,2100.00%
2024/12/13988.2000.0088.8091,2090.74%
2024/12/06293.5000.0093.3021,1800.17%
2024/11/2200.000.196.1093.80-0.11,0310.00%
2024/11/191.196.0300.0096.001.11,0150.10%
2024/11/150100.5000.0099.9009890.00%
2024/11/1300.000.1105.00106.50-0.1946-0.01%
2024/11/081101.501104.00103.0008730.00%
2024/11/0700.000105.00103.5008520.00%
2024/11/061102.021103.50102.5008260.00%
2024/11/051106.001106.50106.0007820.00%
2024/11/014108.884104.88105.0007300.00%
2024/10/293100.503100.67100.5006040.00%
2024/10/281101.001102.00102.0005760.00%
2024/10/2500.00197.7097.40-1513-0.19%
2024/10/24898.649.399.6098.30-1.3494-0.26%
2024/10/180.187.7000.0086.800.14500.01%
2024/10/08292.50492.7891.10-2507-0.39%
2024/10/01088.7000.0089.9005450.00%
2024/09/120.182.4000.0082.200.16510.02%
2024/09/0900.000.281.8082.00-0.2666-0.03%
2024/09/04182.7000.0082.0016980.14%
2024/08/2700.00186.5086.50-1734-0.14%
2024/08/2000.001085.4985.80-10742-1.35%
2024/08/191084.5500.0084.50107391.35%
2024/08/15384.0000.0084.5037450.40%
2024/08/14184.0000.0083.6017550.13%
2024/08/09286.1000.0085.4027830.26%
2024/08/06380.2700.0080.8037830.38%
2024/08/05383.0300.0083.0037640.39%
2024/07/29097.0000.0094.5007360.00%
2024/07/22092.2000.0092.0007180.00%
2024/07/1900.000.198.9694.20-0.1708-0.01%
2024/07/1500.00398.7098.40-3663-0.45%
2024/07/11396.3000.0095.2036500.46%
2024/07/02098.7000.0097.8006230.01%
2024/06/27498.10497.3095.7005820.00%
2024/06/250.193.0000.0094.300.15680.01%
2024/06/0700.00193.5094.50-1644-0.16%
2024/06/06091.8000.0091.1006300.00%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章